| Net sales | 85.48M |
| Cost of sales | 52.03M |
| Gross profit | 33.46M |
| Selling, general and administrative | 18.4M |
| Research and development | 19.89M |
| Amortization | |
| Restructuring | 1.8M |
| Asset impairment | 56.04M |
| Other, net | |
| Total operating expenses | 102.18M |
| Operating income | -68.72M |
| Interest expense, net | |
| Loss on extinguishment of debt | |
| Income from continuing operations before income taxes | -68.46M |
| Income tax provision | 1.14M |
| Income from continuing operations | |
| (Loss) income from discontinued operations before income taxes | |
| Income tax (benefit) provision | |
| (Loss) income from discontinued operations | |
| Net income | |
| Continuing operations (in dollars per share) | |
| Discontinued operations (in dollars per share) | |
| Income (in dollars per share) | -1.78 |
| Continuing operations (in dollars per share) | |
| Discontinued operations (in dollars per share) | |
| Income (in dollars per share) | -1.78 |
| Basic (in shares) | 39.13M |
| Diluted (in shares) | 39.13M |